BioAge Labs, Inc. Common Stock Share Price
NASDAQ: BIOA
Live BioAge Labs, Inc. Common Stock Share Price Chart
O H L
BioAge Labs, Inc. Common Stock Performance Overview
Days Range
▼
$7.93Low
$8.04High
Markets Today
| Previous Close | $8.09 |
|---|---|
| Open | $8.04 |
| Volume | 57,483 |
| Day's Range | $7.93 - $8.04 |
| 52W Range | NA |
| Market Cap | $355.70 M |
Historical Performance
| 1M Returns | -22.66 |
|---|---|
| 3M Returns | -61.05 |
| 6M Returns | -58.21 |
| 1Y Returns | +54.98 |
| 5Y Returns | NA |
| 10Y Returns | +116.31 |
BioAge Labs, Inc. Common Stock Fundamentals
| Market Cap | $355.70 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $8.99 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-92.57 M |
| Profit Margin | -896.11 |
| Market Cap | $355.70 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $8.99 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-92.57 M |
| Profit Margin | -896.11 |
BioAge Labs, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $1.45 M | $2.41 M | $2.05 M | $3.08 M | $2.77 M | $2.45 M |
| Gross Profit + | $1.45 M | $2.41 M | $2.05 M | $3.08 M | $2.77 M | $2.45 M |
| Operating Income | -$16.45 M | -$24.77 M | -$23.14 M | -$28.42 M | -$25.38 M | -$29.33 M |
| EBITDA | -$16.41 M | -$24.71 M | -$23.09 M | -$28.35 M | -$25.31 M | -$29.26 M |
| Interest Expense | -$255.00 K | -$201.00 K | -$149.00 K | -$92.00 K | -$39.00 K | -$1.00 K |
| Depreciation | $37.00 K | $58.00 K | $49.00 K | $69.00 K | $63.00 K | $70.00 K |
| Income Before Tax | -$12.93 M | -$21.56 M | -$20.17 M | -$25.94 M | -$22.25 M | -$26.10 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$12.93 M | -$21.56 M | -$20.17 M | -$25.94 M | -$22.25 M | -$26.10 M |
| Net Profit Margin | -890.97% | -893.99% | -982.04% | -842.85% | -802.78% | -1064.75% |
BioAge Labs, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $0 | $0 | $0 | $0 | $0 | $0 |
| Reserve & Surplus | -$265.48 M | -$287.09 M | -$307.20 M | -$333.14 M | -$355.60 M | -$382.24 M |
| Non-Current Liabilities | $6.94 M | $4.53 M | $3.13 M | $2.70 M | $2.71 M | $2.80 M |
| Current Liabilities | $23.74 M | $22.84 M | $24.49 M | $20.14 M | $15.83 M | $19.22 M |
| Total Liabilities | $30.67 M | $27.37 M | $27.63 M | $22.84 M | $18.53 M | $22.02 M |
| Fixed Assets | $929.00 K | $974.00 K | $973.00 K | $963.00 K | $1.11 M | $1.21 M |
| Current Assets | $324.81 M | $301.70 M | $290.83 M | $286.79 M | $391.86 M | $330.31 M |
| Total Assets | $343.84 M | $322.15 M | $305.09 M | $294.89 M | $397.65 M | $396.93 M |
BioAge Labs, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$12.93 M | -$21.56 M | -$20.17 M | -$25.94 M | -$22.25 M | -$26.10 M |
| Operating Cash Flow | -$17.36 M | -$19.97 M | -$16.04 M | -$28.25 M | -$24.05 M | -$19.26 M |
| Investing Cash Flow | -$77.99 M | -$15.64 M | $12.84 M | -$14.43 M | -$46.75 M | -$164.51 M |
| Financing Cash Flow | -$1.50 M | -$1.50 M | -$1.54 M | $16.01 M | $123.72 M | $15.97 M |
| Change in Cash | -$96.86 M | -$37.16 M | -$4.76 M | -$26.68 M | $52.89 M | -$167.81 M |
BioAge Labs, Inc. Common Stock Return Calculator
The BioAge Labs, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About BioAge Labs, Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Popular Stocks
FAQs
What is the share price of BioAge Labs, Inc. Common Stock today?
BioAge Labs, Inc. Common Stock (BIOA) share price as of September 18, 2026 is $7.82. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of BioAge Labs, Inc. Common Stock?
Yes, Indian Investors can invest in the BioAge Labs, Inc. Common Stock (BIOA) Share by opening an international trading account with Angel One.
How can I purchase BioAge Labs, Inc. Common Stock shares in India?
Purchasing BioAge Labs, Inc. Common Stock (BIOA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying BioAge Labs, Inc. Common Stock (BIOA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of BioAge Labs, Inc. Common Stock?
Yes, you can purchase fractional shares of BioAge Labs, Inc. Common Stock (BIOA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of BioAge Labs, Inc. Common Stock?
The market capitalization of BioAge Labs, Inc. Common Stock on September 18, 2026, is $355.70 M.
In which sector BioAge Labs, Inc. Common Stock belongs?
BioAge Labs, Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in BioAge Labs, Inc. Common Stock stocks?
In order to invest in BioAge Labs, Inc. Common Stock (BIOA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
